Diagnostic Challenges and Immunological Barriers in Kidney Transplantation
Journal Title: Journal of Clinical & Cellular Immunology - Year 2023, Vol 14, Issue 3
Abstract
The presence of donor specific antibodies and HLA-incompatibility between waiting list patients and potential donors make transplantation programs worldwide complicated and stand as a major barrier for a quick access for organ transplantation. Especially in kidney transplantation, the effector HLA antibodies are the most important reason for graft failures and antibody mediated rejection. At the same time, the demand for kidney transplantation is increasing remarkably worldwide, due to the continuously Raising number of patients with end stage renal disease. For these patients, hemodialysis was regularly considered as an intermediate step only and the ideal goal is to find a suitable kidney as early as possible. However, in case of HLA-incompatibility, the waiting time for an organ is too long and often accompanied with dialysis associated multiple diseases, including physical, social and psychological complications, especially in patients with additional limiting factors, like ABO incompatibility or multi-morbidity. This article provides an overview of the current diagnostic tools for an accurate testing, identification and analysis of HLA-antibodies and addresses the remaining concerns related to their clinical and immunological relevance. It reviews the increasing role of different technologies and approaches to overcome the immunological barriers in kidney transplantation, including the extracorporeal removal of clinically relevant antibodies. In addition, the review suggests avenues for future research on overcoming immunological challenges and inducing immune tolerance in kidney transplantation.
Authors and Affiliations
Rayan Bawayan Khalid Elhassan Ashraf Dada
Keywords
Related Articles
- EP ID EP741779
- DOI 10.35248/2155-9899.23.14.687
- Views 57
- Downloads 0
Hyper IgM Syndromes: A Brief Review of the Pathogenesis, Clinical Features and Management
Primary Immuno Deficiency (PID) disorders are heterogeneous disorders of the innate or the adaptive immune system, leading to recurrent infections that can also predispose to autoimmune diseases and malignancies. Hyper I...
Indoleamine 2,3-Dioxygenase (IDO); Silenced Dendritic Cell Vaccine with Ipilimumab in Treating Metastatic Melanoma Patients: A Case Report
Immunotherapy has revolutionized the treatment landscape for metastatic melanoma. This case report presents the clinical course of a patient with metastatic melanoma who received combination therapy with ipilimumab, a CT...
Secretory IgA and Course of COVID-19 in Patients Receiving a BacteriaBased Immunostimulant Agent in Addition to Background Therapy
Background: Mucosal immunity plays a major role not only in the prevention but probably also in the outcome of COVID-19. An enhanced production of secretory Immunoglobulin A (sIgA) might contribute to the activation of t...
Measurement of Post Challenging Immune Response (Serum?s Th1, Th2 Cytokines and Spleen?s CD Markers) with L.Major Amastigote in Balb/c Mice
Introduction: Leishmaniasis is a disease caused by the Leishmania major parasites and afflicted a large number of people every year. This disease is immunologically complex and in some cases, spontaneous improvement is a...
Exercise-Mediated Immune Protection in Chronic Kidney Disease Decreases Infection and Severe Evolution of COVID-19
It is constantly sought to understand the different mechanisms of action of the immune system to establish potential efficient therapeutic targets for different clinical situations. Thus, the present study aims to expand...